Home
Conditions
Treatments
Trials
Explore
🏠
/
treatments
/
EB-DNK102 dual-targeting CAR-NK cells (CLDN18.2 + MUC1)
/
mega-study
EB-DNK102 dual-targeting CAR-NK cells (CLDN18.2 + MUC1)